Michael A. Fifer MD
Professor of Medicine, Harvard Medical School; Director, Hypertrophic Cardiomyopathy Program, Massachusetts General Hospital
Join to view full profile
55 Fruit StGrb 8Boston, MA 02114
Phone+1 617-726-1832
Fax+1 617-726-7437
Dr. Fifer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1983
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1978 - 1981
Harvard Medical SchoolClass of 1978
Certifications & Licensure
MA State Medical License 1980 - 2027
FL State Medical License 2011 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Oncall, Massachusetts General Hospital, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
Clinical Trials
Publications & Presentations
PubMed
- International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.Ethan J Rowin, Barry J Maron, Konstantinos C Siontis, Albree F Tower-Rader, Daniele Massera
Circulation. 2026-10-06 - 1 citationsExercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.Gregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, Bela Merkely, Michael E Nassif
JAMA Cardiology. 2026-08-01 - 1 citationsClinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International Cohort.Ethan J Rowin, Deacon Z J Lee, Mark V Sherrid, Barry J Maron, Albree F Tower-Rader
JACC. Advances. 2026-07-01
Press Mentions
Effect of Aficamten Compared with Metoprolol on Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Prespecified Analysis of MAPLE-HCMAugust 31st, 2025- Look for Alcohol Septal Ablation in the Next HOCM GuidelineJuly 7th, 2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: